MedPath

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke

Phase 3
Completed
Conditions
Post-stroke Spasticity of the Lower Limb
Interventions
Registration Number
NCT01464307
Lead Sponsor
Merz Pharmaceuticals GmbH
Brief Summary

The purpose of this study is to determine whether injections of Botulinum toxin type A into muscles of the leg are effective in treating patients with increased muscle tension/uncontrollable muscle stiffness (spasticity) after a stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
290
Inclusion Criteria
  • Age from 18-80 yrs
  • Lower limb spasticity
  • Time since stroke greater than 3 months
  • Need for 400 U Botulinum toxin type A
Read More
Exclusion Criteria
  • Body weight below 50kg
  • Fixed contractures of the lower limb
  • Generalized disorders of muscle activity like Myasthenia gravis that preclude use of Botulinum toxin type A
  • Infection at the injection site
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IncobotulinumtoxinA (Xeomin) 400 UnitsIncobotulinumtoxinA (400 Units)IncobotulinumtoxinA (Xeomin, also known as "NT 201" or "Botulinum toxin type A (150 kiloDalton), free from complexing proteins") (active ingredient: Clostridium Botulinum neurotoxin Type A free from complexing proteins) powder for solution for injection.
Placebo Comparator ArmPlacebo ComparatorPlacebo to incobotulinumtoxinA (Xeomin) powder for solution for injection.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Ashworth Scale (AS) for Plantar Flexors at Week 4Baseline and Week 4

The AS is a well known and commonly used scale in clinical trials with spasticity. It was considered to be the best clinical tool for measuring resistance to movement. It was used to categorize the severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Co-primary Variable: Investigator's Global Assessment of Efficacy at Week 12Baseline to Week 12

A 4-point Likert scale will be used with the ratings 1 = very good, 2 = good, 3 = moderate, and 4 = poor. Investigator's Global Assessment of Efficacy at Week 12 will be a co-primary outcome measure to fulfill post marketing commitments for U.S. regulatory authorities only. Elsewhere, it will be a secondary outcome measure.

Secondary Outcome Measures
NameTimeMethod
Response Rate for Plantar Flexors at All Post-Baseline Visits for Subjects With an Improvement (Reduction) of at Least 1 Point From Baseline in the Ashworth Scale (AS)Week 4, 8, and 12

Response is defined as an improvement (reduction) of the plantar flexor Ashworth Score by at least one score point. The AS is a well known and commonly used scale in clinical trials with spasticity. It was considered to be the best clinical tool for measuring resistance to movement. It was used to categorize the severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension).

Ashworth Scale (AS) for Plantar Flexors at All Post-Baseline VisitsBaseline, Week 4, 8, and 12

The AS is a well known and commonly used scale in clinical trials with spasticity. It was considered to be the best clinical tool for measuring resistance to movement. It was used to categorize the severity of spasticity by judging resistance to passive movement. It is a 5-point scale that ranges from 0 (=no increase in tone) to 4 (=limb rigid in flexion or extension). Here, 'n' specifies those subjects who were evaluated for this outcome measure at given time point.

Trial Locations

Locations (53)

Merz Investigational Site #420024

🇨🇿

Ostrava-Poruba, Czech Republic

Merz Investigational Site #001208

🇺🇸

Long Beach, California, United States

Merz Investigational Site #001204

🇨🇦

Halifax, Nova Scotia, Canada

Merz Investigational Site #001183

🇺🇸

Houston, Texas, United States

Merz Investigational Site #001184

🇺🇸

Downey, California, United States

Merz Investigational Site #001244

🇺🇸

Fairfield, Connecticut, United States

Merz Investigational Site #001207

🇺🇸

Plainview, New York, United States

Merz Investigational Site #420047

🇨🇿

Rychnov nad Kneznou, Czech Republic

Investigational site #001188

🇺🇸

Doral, Florida, United States

Merz Investigational Site # 001110

🇺🇸

Overland Park, Kansas, United States

Merz Investigational Site #001209

🇺🇸

Columbia, Missouri, United States

Merz Investigational Site #001009

🇺🇸

Winston-Salem, North Carolina, United States

Merz Investigational Site #001206

🇺🇸

Nashville, Tennessee, United States

Merz Investigational Site #420031

🇨🇿

Ostrava-Vitkovice, Czech Republic

Merz Investigational Site #033018

🇫🇷

Garches, France

Merz Investigational Site #049071

🇩🇪

Düsseldorf, Germany

Merz Investigational Site #049072

🇩🇪

München, Germany

Merz Investigational Site #420030

🇨🇿

Praha, Czech Republic

Merz Investigational Site #001202

🇨🇦

Winnipeg, Canada

Merz Investigational Site #033024

🇫🇷

Rennes, France

Merz Investigational Site #049022

🇩🇪

Beelitz-Heilstätten, Germany

Merz Investigational Site #048044

🇵🇱

Kielce, Poland

Merz Investigational Site #048053

🇵🇱

Poznan, Poland

Merz Investigational Site #048023

🇵🇱

Warszawa, Poland

Merz Investigational Site #049079

🇩🇪

Hamburg, Germany

Merz Investigational Site #039006

🇮🇹

Messina, Italy

Merz Investigational Site #049303

🇩🇪

Regensburg, Germany

Merz Investigational Site #049148

🇩🇪

München, Germany

Merz Investigational Site #049304

🇩🇪

Kiel, Germany

Merz Investigational Site #048080

🇵🇱

Krakow, Poland

Merz Investigational Site #039012

🇮🇹

Roma, Italy

Merz Investigational Site #039011

🇮🇹

Roma, Italy

Merz Investigational Site #048031

🇵🇱

Krakow, Poland

Merz Investigational Site #007010

🇷🇺

Krasnoyarsk, Russian Federation

Merz Investigational Site #034027

🇪🇸

Madrid, Spain

Merz Investigational Site #007009

🇷🇺

St. Petersburg, Russian Federation

Merz Investigational Site #034030

🇪🇸

Sevilla, Spain

Merz Investigational Site #034028

🇪🇸

Majadahonda, Spain

Merz Investigational Site #034026

🇪🇸

Sevilla, Spain

Merz Investigational Site #007012

🇷🇺

Stavropol, Russian Federation

Merz Investigational Site #001198

🇺🇸

Stratford, New Jersey, United States

Merz Investigational Site #048057

🇵🇱

Gdansk, Poland

Merz Investigational Site #049302

🇩🇪

Würzburg, Germany

Merz Investigational Site #048051

🇵🇱

Lublin, Poland

Merz Investigational Site #048054

🇵🇱

Krakow, Poland

Merz Investigational Site #048022

🇵🇱

Lodz, Poland

Merz Investigational Site #007011

🇷🇺

Moscow, Russian Federation

Merz Investigational Site #034029

🇪🇸

Terrassa, Spain

Merz Investigational Site #001210

🇺🇸

St. Louis, Missouri, United States

Merz Investigational Site #048055

🇵🇱

Warszawa, Poland

Merz Investigational Site #048033

🇵🇱

Warszawa, Poland

Merz Investigational Site #048081

🇵🇱

Poznan, Poland

Merz Investigational Site #048056

🇵🇱

Warszawa, Poland

© Copyright 2025. All Rights Reserved by MedPath